Jiangxi Serum Pharma Industries Co., Ltd. is a professional supplier of pharmaceutical and nutritional products in China. For nearly 10 years, we have been dedicated to exporting biological products, vaccines, Western medicines, raw materials, intermediates, medical consumables, food additives, and plant extracts, and have accumulated rich industry experience.
Our commitment to the E-E-A-T (Experience, Expertise, Authoritativeness, and Trustworthiness) principle ensures that every batch of product meeting the stringent requirements of international pharmacopoeias (USP, BP, EP). With a decade of market presence, we bridge the gap between high-end Chinese manufacturing and global healthcare needs.
Established Year
Global Long-term Clients
Certified Supplier Network
Annual Export Volume
The global shift toward biologics is accelerating. As patents for major reference products expire, the demand for high-quality biosimilars and vaccine platforms (mRNA, Viral Vector) is skyrocketing. Our focus on Bio-Fermentation technologies positions us at the forefront of this revolution.
Global procurement strategies are moving away from "single-source" dependency. Supply chain managers are seeking diversified API (Active Pharmaceutical Ingredient) sources that offer both regulatory compliance (GMP, CEP) and cost-efficiency. China remains the vital hub for this global rebalancing.
The move from "one-size-fits-all" to "precision medicine" requires more complex intermediates and specialized delivery systems. Small-molecule innovation, such as the rapid approval of oral GLP-1 weight-loss drugs, demonstrates the industry's agility in meeting modern consumer health demands.
The concept of China Factory 4.0 is not just about automation; it's about the integration of AI-driven quality control and flexible manufacturing systems. At Jiangxi Serum Pharma, we leverage these advantages to offer:
Our strategic partnerships enable us to provide specialized services like Pre-Mix, Co-Crystallization, and Bio-Fermentation, meeting the exact specifications of international pharmaceutical conglomerates.
Derived from nature to maintain body health and balance with purity. Our plant-derived Squalene and essential oils are processed using low-temperature extraction to preserve bio-activity.
Supporting gut health through advanced stabilization techniques. Our probiotic strains are tested for shelf-life stability and gastric acid resistance.
Including high-purity food additives and nutritional catalysts that enhance the efficacy of final health formulations.
In large-scale farming across Southeast Asia and Africa, our Ivermectin Injections and Amoxicillin soluble powders are critical for preventing parasitic outbreaks and bacterial infections, directly impacting food security.
The urban pet market in Europe and North America demands human-grade pharmaceutical quality. Our Flunixin Meglumine and Enrofloxacin oral solutions provide fast-acting relief for domestic animals with high bioavailability.
For global pharmaceutical manufacturers, we provide the building blocks for complex synthesis. Our Co-Crystallization service allows for the improvement of API solubility and stability, crucial for the next generation of oral medications.
Customized blending services for feed additives and nutritional supplements. We ensure homogeneous distribution of active ingredients to prevent dosage inconsistencies.
A cutting-edge technique used to modify the physical properties of an API without changing its chemical structure, enhancing absorption and patent life.
Utilizing high-yield microbial strains to produce amino acids, vitamins, and antibiotics through sustainable and eco-friendly biological processes.
Explore the transition from shark-derived to plant-based squalene in the vaccine and cosmetic industries, driven by sustainability and ethical sourcing trends.
Why this critical molecule remains a cornerstone in modern medicine for inflammatory diseases and emergency respiratory care.
Analysis of Eli Lilly's Foundayo™ approval: The world's first oral GLP-1 weight-loss drug that requires no fasting or water restriction, revolutionizing patient compliance.
